← Back to Search

Non-Pharmacological Therapy

rTMS active treatment for Alzheimer's Disease

N/A
Waitlist Available
Led By Zahra Moussavi, PhD
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weeks 3, 5, 11, 19, and 27 for the 2 week group and weeks 0, 3, 5, 13, 21, and 29 for the 4 week groups
Awards & highlights

Study Summary

This study is evaluating whether repetitive Transcranial Magnetic Stimulation (rTMS) treatment can improve memory in people with Alzheimer's disease.

Eligible Conditions
  • Alzheimer's Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weeks 3, 5, 11, 19, and 27 for the 2 week group and weeks 0, 3, 5, 13, 21, and 29 for the 4 week groups
This trial's timeline: 3 weeks for screening, Varies for treatment, and weeks 3, 5, 11, 19, and 27 for the 2 week group and weeks 0, 3, 5, 13, 21, and 29 for the 4 week groups for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-Cog) change
Secondary outcome measures
Alzheimer's Disease
Alzheimer's Disease Cooperative Study-Activities of Daily Living (ADCS-ADL)
Clinical Dementia Rating (CDR) sum of boxes
+7 more

Trial Design

4Treatment groups
Experimental Treatment
Placebo Group
Group I: 4 weeks active treatmentExperimental Treatment1 Intervention
4 weeks of rTMS active treatment applied using an active rTMS coil.
Group II: 2 weeks active treatmentExperimental Treatment1 Intervention
2 weeks of rTMS active treatment applied using an active rTMS coil.
Group III: 4 weeks sham treatmentPlacebo Group1 Intervention
4 weeks of rTMS sham treatment applied using a modified rTMS coil which does not stimulate the brain.
Group IV: 2 weeks sham treatmentPlacebo Group1 Intervention
2 weeks of rTMS sham treatment applied using a modified rTMS coil which does not stimulate the brain.

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor
595 Previous Clinical Trials
199,326 Total Patients Enrolled
Zahra Moussavi, PhDPrincipal InvestigatorDepartment of Biomedical Engineering, University of Manitoba

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Investigating the Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) as a Treatment for Alzheimer's Disease
2016. "Investigating the Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) as a Treatment for Alzheimer's Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02908815.
All > Transcranial Magnetic Stimulation
~24 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top